BPC 157 Banned: Key Facts on the Latest FDA Decision BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & RFK Jr. and the Perils of Peptides Washington Monthly FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times